UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041942
Receipt number R000047830
Scientific Title Research of health-related QOL with EQ-5D-5L using a web application by community pharmacists
Date of disclosure of the study information 2020/09/30
Last modified on 2022/03/31 23:23:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research of health-related QOL with EQ-5D-5L using a web application by community pharmacists

Acronym

Research of health-related QOL with EQ-5D-5L using a web application by community pharmacists

Scientific Title

Research of health-related QOL with EQ-5D-5L using a web application by community pharmacists

Scientific Title:Acronym

Research of health-related QOL with EQ-5D-5L using a web application by community pharmacists

Region

Japan


Condition

Condition

All diseases; patients who have been issued prescriptions for treatment

Classification by specialty

Medicine in general Surgery in general Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Clarify the change of health-related QOL during treatment

Basic objectives2

Others

Basic objectives -Others

Clarify adverse events affecting health-related QOL

Trial characteristics_1

Others

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

An observation period of 6 months or more will be provided from the start of registration. Health-related QOL is measured 4 or more times during the observation period. The primary endpoint is quality-adjusted life years (QALY).

Key secondary outcomes

Adverse event


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)Patients who are 20 years old or more at the time of consent acquisition.
(2) Patients provided written informed consent
(3)Patients who have been issued prescriptions by medical institutions

Key exclusion criteria

(1)Requested for cancellation from patients
(2)Interrupted due to the circumstances of the research patients (moving, changing doctor / hospital, busy, unfollowable)
(3)Judged that evaluation is not possible due to serious deviation from protocol
(4)Patients judged inappropriate in this study

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name Hisanori
Middle name
Last name Shimizu

Organization

The Cancer Institute Hospital of Japanese Foundation for Cancer Research

Division name

Department of Pharmacy

Zip code

135-8550

Address

3-8-31, Ariake, Koto-ku, Tokyo, Japan

TEL

03-3570-0214

Email

hisanori.shimizu@jfcr.or.jp


Public contact

Name of contact person

1st name Hayato
Middle name
Last name Murata

Organization

Qol Co., Ltd.

Division name

Kanto Pharmacy Headquarter 1

Zip code

224-0032

Address

36-6, Chigasakichuo, Tsuzuki-ku, Yokohama, Kanagawa, Japan

TEL

045-949-5800

Homepage URL


Email

hayato-m@pharm.showa-u.ac.jp


Sponsor or person

Institute

School of Nursing and Rehabilitation Sciences, Showa University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare
Health Labour Sciences Research Grant
Geriatric Oncology Guideline-establishing (GOGGLE) Study Group; Geriatric Oncology Guideline-establishing (GOGGLE) Study

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

(1)QOL Co., Ltd.
(2)Nihon Chouzai Co., Ltd.
(3)KRAFT Inc.
(4)SOGO MEDICAL CO., LTD
(5)AIN PHARMACIEZ INC.
(6)Study group for Comprehensive Cost-Effectiveness Analysis of Pharmacotherapy

Name of secondary funder(s)



IRB Contact (For public release)

Organization

School of Nursing and Rehabilitation Sciences, Showa University

Address

1865, Tokaichibacho, Midori-ku, Yokohama, Kanagawa, Japan

Tel

045-985-6503

Email

nr-rinri@ofc.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

(1)クオール株式会社
(2)日本調剤株式会社
(3)クラフト株式会社
(4)総合メディカル株式会社
(5)株式会社アインファーマシーズ


Other administrative information

Date of disclosure of the study information

2020 Year 09 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 07 Month 15 Day

Date of IRB

2020 Year 07 Month 15 Day

Anticipated trial start date

2020 Year 10 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 03 Month 31 Day

Date trial data considered complete

2022 Year 03 Month 31 Day

Date analysis concluded

2022 Year 09 Month 30 Day


Other

Other related information

We research health-related QOL with EQ-5D-5L using a web application; prospective observational study.


Management information

Registered date

2020 Year 09 Month 29 Day

Last modified on

2022 Year 03 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047830


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name